Loading…

5PSQ-026 Impact of the early switching from intravenous to oral antibiotics in a tertiary hospital

Background and importanceOne of the strategies for the rational use of antibiotics is conversion of intravenous antibiotic treatment to oral as soon as possible, without compromising the therapeutic response of the patient. This can reduce the number of possible adverse effects associated with paren...

Full description

Saved in:
Bibliographic Details
Published in:European journal of hospital pharmacy. Science and practice 2020-03, Vol.27 (Suppl 1), p.A161-A161
Main Authors: Ortiz Latorre, JL, Toscano Guzmán, MD, Gómez Delgado, M, Moya Carmona, I
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page A161
container_issue Suppl 1
container_start_page A161
container_title European journal of hospital pharmacy. Science and practice
container_volume 27
creator Ortiz Latorre, JL
Toscano Guzmán, MD
Gómez Delgado, M
Moya Carmona, I
description Background and importanceOne of the strategies for the rational use of antibiotics is conversion of intravenous antibiotic treatment to oral as soon as possible, without compromising the therapeutic response of the patient. This can reduce the number of possible adverse effects associated with parenteral use and have an economic impact.Aim and objectivesThis study was conducted to promote early switching from intravenous to oral treatment in patients who were prescribed parenteral antibiotic treatment for >3 days and to analyse the degree of acceptance of the interventions performed by the pharmacists.Material and methodsA prospective interventional study was carried out between February and April 2019. All patients receiving intravenous antibiotic treatment for >3 days were analysed by two pharmacists. Antibiotics included levofloxacin, ciprofloxacin, linezolid and metronidazole. The oral switch was proposed in patients who tolerated oral administration, with no fever and decrease in inflammatory markers (leucocytes and C reactive protein) and whose clinical condition had improved. Those excluded were critically ill patients and infections that were not candidates for sequential therapy (CNS infections, undrained abscesses, endocarditis and endovascular prosthetic infections).The intervention consisted of a message from the pharmacist sent through the electronic prescription programme to the responsible physician with a recommendation to switch to oral administration. Data were extracted from the management software (Farmatools) and collected in an Excel spreadsheet.ResultsA total of 117 patients were selected (53.9% men, median age 69 years). Patients were hospitalised in: pneumology (48.7%), surgery (18.8%) and internal medicine (8.6%). An intervention was made in 57 (48.7%) patients. In 78.9% (45) the intervention was accepted and 21.1% (12) were denied by medical staff. Antibiotic, number of interventions (percentage of total) and number of interventions accepted (percentage) were: levofloxacin n=40 (70.4%), acceptance 33 (82.5%); metronidazole n=7 (12.2%), acceptance 4 (57.1%); ciprofloxacin n=6 (10.5%), acceptance 4 (66%); and linezolid n=4 (7.0%), acceptance 4 (100%).Conclusion and relevanceReview of antibiotic prescriptions by the pharmacist service increased early sequential therapy, and the degree of acceptance by medical staff was high. This was related to a decrease in adverse effects and costs per patient.References and/or acknowledgementsNo
doi_str_mv 10.1136/ejhpharm-2020-eahpconf.343
format article
fullrecord <record><control><sourceid>proquest_bmj_p</sourceid><recordid>TN_cdi_proquest_journals_2382936445</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2382936445</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1263-849c898666856e21b684ed4e6767e6a7af048b417cf05e4964ffb1cdc7ff2a223</originalsourceid><addsrcrecordid>eNo9kM1KAzEUhYMoWGrfIeh6av4mkyyl-FMoqKjrkEkTJ2VmMiap4s6NL-qTOKXW1T1wD-fe8wFwjtEcY8ov7aYZGh27giCCCqubwYTezSmjR2BCEKsKKTk7_tclPwWzlHyNSkqFZFROwLp8eHosEOE_X9_LbtAmw-Bgbiy0OrafMH34bBrfv0IXQwd9n6N-t33YJpgDDFG3UPfZ1z5kb9K4hxpmG7PX8RM2IQ0-6_YMnDjdJjv7m1PwcnP9vLgrVve3y8XVqqgx4bQQTBohBedclNwSXHPB7JpZXvHKcl1ph5ioGa6MQ6VlYzfnamzWpnKOaELoFFzsc4cY3rY2ZbUJ29iPJxWhgkjKGStHV7l31d1GDdF346sKI7Vjqg5M1Y6pOjBVI1P6Cw-7cJI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2382936445</pqid></control><display><type>article</type><title>5PSQ-026 Impact of the early switching from intravenous to oral antibiotics in a tertiary hospital</title><source>PubMed Central</source><creator>Ortiz Latorre, JL ; Toscano Guzmán, MD ; Gómez Delgado, M ; Moya Carmona, I</creator><creatorcontrib>Ortiz Latorre, JL ; Toscano Guzmán, MD ; Gómez Delgado, M ; Moya Carmona, I</creatorcontrib><description>Background and importanceOne of the strategies for the rational use of antibiotics is conversion of intravenous antibiotic treatment to oral as soon as possible, without compromising the therapeutic response of the patient. This can reduce the number of possible adverse effects associated with parenteral use and have an economic impact.Aim and objectivesThis study was conducted to promote early switching from intravenous to oral treatment in patients who were prescribed parenteral antibiotic treatment for &gt;3 days and to analyse the degree of acceptance of the interventions performed by the pharmacists.Material and methodsA prospective interventional study was carried out between February and April 2019. All patients receiving intravenous antibiotic treatment for &gt;3 days were analysed by two pharmacists. Antibiotics included levofloxacin, ciprofloxacin, linezolid and metronidazole. The oral switch was proposed in patients who tolerated oral administration, with no fever and decrease in inflammatory markers (leucocytes and C reactive protein) and whose clinical condition had improved. Those excluded were critically ill patients and infections that were not candidates for sequential therapy (CNS infections, undrained abscesses, endocarditis and endovascular prosthetic infections).The intervention consisted of a message from the pharmacist sent through the electronic prescription programme to the responsible physician with a recommendation to switch to oral administration. Data were extracted from the management software (Farmatools) and collected in an Excel spreadsheet.ResultsA total of 117 patients were selected (53.9% men, median age 69 years). Patients were hospitalised in: pneumology (48.7%), surgery (18.8%) and internal medicine (8.6%). An intervention was made in 57 (48.7%) patients. In 78.9% (45) the intervention was accepted and 21.1% (12) were denied by medical staff. Antibiotic, number of interventions (percentage of total) and number of interventions accepted (percentage) were: levofloxacin n=40 (70.4%), acceptance 33 (82.5%); metronidazole n=7 (12.2%), acceptance 4 (57.1%); ciprofloxacin n=6 (10.5%), acceptance 4 (66%); and linezolid n=4 (7.0%), acceptance 4 (100%).Conclusion and relevanceReview of antibiotic prescriptions by the pharmacist service increased early sequential therapy, and the degree of acceptance by medical staff was high. This was related to a decrease in adverse effects and costs per patient.References and/or acknowledgementsNo conflict of interest.</description><identifier>ISSN: 2047-9956</identifier><identifier>EISSN: 2047-9964</identifier><identifier>DOI: 10.1136/ejhpharm-2020-eahpconf.343</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><subject>Antibiotics ; Infections ; Intervention ; Patients ; Pharmacists</subject><ispartof>European journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A161-A161</ispartof><rights>Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Ortiz Latorre, JL</creatorcontrib><creatorcontrib>Toscano Guzmán, MD</creatorcontrib><creatorcontrib>Gómez Delgado, M</creatorcontrib><creatorcontrib>Moya Carmona, I</creatorcontrib><title>5PSQ-026 Impact of the early switching from intravenous to oral antibiotics in a tertiary hospital</title><title>European journal of hospital pharmacy. Science and practice</title><description>Background and importanceOne of the strategies for the rational use of antibiotics is conversion of intravenous antibiotic treatment to oral as soon as possible, without compromising the therapeutic response of the patient. This can reduce the number of possible adverse effects associated with parenteral use and have an economic impact.Aim and objectivesThis study was conducted to promote early switching from intravenous to oral treatment in patients who were prescribed parenteral antibiotic treatment for &gt;3 days and to analyse the degree of acceptance of the interventions performed by the pharmacists.Material and methodsA prospective interventional study was carried out between February and April 2019. All patients receiving intravenous antibiotic treatment for &gt;3 days were analysed by two pharmacists. Antibiotics included levofloxacin, ciprofloxacin, linezolid and metronidazole. The oral switch was proposed in patients who tolerated oral administration, with no fever and decrease in inflammatory markers (leucocytes and C reactive protein) and whose clinical condition had improved. Those excluded were critically ill patients and infections that were not candidates for sequential therapy (CNS infections, undrained abscesses, endocarditis and endovascular prosthetic infections).The intervention consisted of a message from the pharmacist sent through the electronic prescription programme to the responsible physician with a recommendation to switch to oral administration. Data were extracted from the management software (Farmatools) and collected in an Excel spreadsheet.ResultsA total of 117 patients were selected (53.9% men, median age 69 years). Patients were hospitalised in: pneumology (48.7%), surgery (18.8%) and internal medicine (8.6%). An intervention was made in 57 (48.7%) patients. In 78.9% (45) the intervention was accepted and 21.1% (12) were denied by medical staff. Antibiotic, number of interventions (percentage of total) and number of interventions accepted (percentage) were: levofloxacin n=40 (70.4%), acceptance 33 (82.5%); metronidazole n=7 (12.2%), acceptance 4 (57.1%); ciprofloxacin n=6 (10.5%), acceptance 4 (66%); and linezolid n=4 (7.0%), acceptance 4 (100%).Conclusion and relevanceReview of antibiotic prescriptions by the pharmacist service increased early sequential therapy, and the degree of acceptance by medical staff was high. This was related to a decrease in adverse effects and costs per patient.References and/or acknowledgementsNo conflict of interest.</description><subject>Antibiotics</subject><subject>Infections</subject><subject>Intervention</subject><subject>Patients</subject><subject>Pharmacists</subject><issn>2047-9956</issn><issn>2047-9964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNo9kM1KAzEUhYMoWGrfIeh6av4mkyyl-FMoqKjrkEkTJ2VmMiap4s6NL-qTOKXW1T1wD-fe8wFwjtEcY8ov7aYZGh27giCCCqubwYTezSmjR2BCEKsKKTk7_tclPwWzlHyNSkqFZFROwLp8eHosEOE_X9_LbtAmw-Bgbiy0OrafMH34bBrfv0IXQwd9n6N-t33YJpgDDFG3UPfZ1z5kb9K4hxpmG7PX8RM2IQ0-6_YMnDjdJjv7m1PwcnP9vLgrVve3y8XVqqgx4bQQTBohBedclNwSXHPB7JpZXvHKcl1ph5ioGa6MQ6VlYzfnamzWpnKOaELoFFzsc4cY3rY2ZbUJ29iPJxWhgkjKGStHV7l31d1GDdF346sKI7Vjqg5M1Y6pOjBVI1P6Cw-7cJI</recordid><startdate>202003</startdate><enddate>202003</enddate><creator>Ortiz Latorre, JL</creator><creator>Toscano Guzmán, MD</creator><creator>Gómez Delgado, M</creator><creator>Moya Carmona, I</creator><general>BMJ Publishing Group LTD</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>202003</creationdate><title>5PSQ-026 Impact of the early switching from intravenous to oral antibiotics in a tertiary hospital</title><author>Ortiz Latorre, JL ; Toscano Guzmán, MD ; Gómez Delgado, M ; Moya Carmona, I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1263-849c898666856e21b684ed4e6767e6a7af048b417cf05e4964ffb1cdc7ff2a223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antibiotics</topic><topic>Infections</topic><topic>Intervention</topic><topic>Patients</topic><topic>Pharmacists</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ortiz Latorre, JL</creatorcontrib><creatorcontrib>Toscano Guzmán, MD</creatorcontrib><creatorcontrib>Gómez Delgado, M</creatorcontrib><creatorcontrib>Moya Carmona, I</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>European journal of hospital pharmacy. Science and practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ortiz Latorre, JL</au><au>Toscano Guzmán, MD</au><au>Gómez Delgado, M</au><au>Moya Carmona, I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>5PSQ-026 Impact of the early switching from intravenous to oral antibiotics in a tertiary hospital</atitle><jtitle>European journal of hospital pharmacy. Science and practice</jtitle><date>2020-03</date><risdate>2020</risdate><volume>27</volume><issue>Suppl 1</issue><spage>A161</spage><epage>A161</epage><pages>A161-A161</pages><issn>2047-9956</issn><eissn>2047-9964</eissn><abstract>Background and importanceOne of the strategies for the rational use of antibiotics is conversion of intravenous antibiotic treatment to oral as soon as possible, without compromising the therapeutic response of the patient. This can reduce the number of possible adverse effects associated with parenteral use and have an economic impact.Aim and objectivesThis study was conducted to promote early switching from intravenous to oral treatment in patients who were prescribed parenteral antibiotic treatment for &gt;3 days and to analyse the degree of acceptance of the interventions performed by the pharmacists.Material and methodsA prospective interventional study was carried out between February and April 2019. All patients receiving intravenous antibiotic treatment for &gt;3 days were analysed by two pharmacists. Antibiotics included levofloxacin, ciprofloxacin, linezolid and metronidazole. The oral switch was proposed in patients who tolerated oral administration, with no fever and decrease in inflammatory markers (leucocytes and C reactive protein) and whose clinical condition had improved. Those excluded were critically ill patients and infections that were not candidates for sequential therapy (CNS infections, undrained abscesses, endocarditis and endovascular prosthetic infections).The intervention consisted of a message from the pharmacist sent through the electronic prescription programme to the responsible physician with a recommendation to switch to oral administration. Data were extracted from the management software (Farmatools) and collected in an Excel spreadsheet.ResultsA total of 117 patients were selected (53.9% men, median age 69 years). Patients were hospitalised in: pneumology (48.7%), surgery (18.8%) and internal medicine (8.6%). An intervention was made in 57 (48.7%) patients. In 78.9% (45) the intervention was accepted and 21.1% (12) were denied by medical staff. Antibiotic, number of interventions (percentage of total) and number of interventions accepted (percentage) were: levofloxacin n=40 (70.4%), acceptance 33 (82.5%); metronidazole n=7 (12.2%), acceptance 4 (57.1%); ciprofloxacin n=6 (10.5%), acceptance 4 (66%); and linezolid n=4 (7.0%), acceptance 4 (100%).Conclusion and relevanceReview of antibiotic prescriptions by the pharmacist service increased early sequential therapy, and the degree of acceptance by medical staff was high. This was related to a decrease in adverse effects and costs per patient.References and/or acknowledgementsNo conflict of interest.</abstract><cop>London</cop><pub>BMJ Publishing Group LTD</pub><doi>10.1136/ejhpharm-2020-eahpconf.343</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2047-9956
ispartof European journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A161-A161
issn 2047-9956
2047-9964
language eng
recordid cdi_proquest_journals_2382936445
source PubMed Central
subjects Antibiotics
Infections
Intervention
Patients
Pharmacists
title 5PSQ-026 Impact of the early switching from intravenous to oral antibiotics in a tertiary hospital
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T02%3A11%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_bmj_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=5PSQ-026%E2%80%85Impact%20of%20the%20early%20switching%20from%20intravenous%20to%20oral%20antibiotics%20in%20a%20tertiary%20hospital&rft.jtitle=European%20journal%20of%20hospital%20pharmacy.%20Science%20and%20practice&rft.au=Ortiz%20Latorre,%20JL&rft.date=2020-03&rft.volume=27&rft.issue=Suppl%201&rft.spage=A161&rft.epage=A161&rft.pages=A161-A161&rft.issn=2047-9956&rft.eissn=2047-9964&rft_id=info:doi/10.1136/ejhpharm-2020-eahpconf.343&rft_dat=%3Cproquest_bmj_p%3E2382936445%3C/proquest_bmj_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b1263-849c898666856e21b684ed4e6767e6a7af048b417cf05e4964ffb1cdc7ff2a223%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2382936445&rft_id=info:pmid/&rfr_iscdi=true